OBJECTIVE
To describe the effect of a specific c‐kit receptor inhibitor (imatinib mesylate) on human detrusor strips in vitro and guinea‐pig cystometry in vivo, and to show histological data suggesting differences in the distribution of interstitial cells of Cajal (ICC)‐like cells in ‘normal’ and overactive human detrusor, as these cells have been identified as possible mediators of spontaneous activity and excitability in bladder smooth muscle.
MATERIALS AND METHODS
Specimens of human detrusor were stained immunohistochemically with a c‐kit antibody. Human detrusor strips were mounted in a superfused organ‐bath apparatus, and smooth muscle contraction was evoked with carbachol and electrical field stimulation in the presence and absence of imatinib mesylate. Also, guinea‐pig urodynamic studies were conducted before and after i.v. administration of imatinib mesylate, and changes in bladder variables and spontaneous activity were recorded.
RESULTS
Imatinib mesylate (10−6M) inhibited evoked smooth muscle contraction and spontaneous activity in overactive human detrusor, with less effect on normal human tissue. Imatinib mesylate (10−5M) improved bladder capacity, compliance, voided volumes, urinary frequency, and reduced contraction thresholds and spontaneous activity during guinea‐pig cystometry. c‐kit labelling showed significantly more ICC‐like cells in overactive human detrusor than in normal specimens.
CONCLUSION
c‐kit receptor blockers have inhibitory effects on guinea‐pig and overactive human detrusor, possibly via c‐kit receptors on bladder ICC‐like cells. This and the possibility that there are more ICC‐like cells in overactive bladder suggest that the c‐kit receptor may provide a novel target for treating detrusor overactivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.